BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31101540)

  • 1. A new delineation method research of the clinical target volume for pancreatic cancer adjuvant radiotherapy.
    Zhang TT; Wei L; Yuan GW; Zhao DQ; Zhang ML; Zhang GF; Wang PC
    Cancer Radiother; 2019 Jun; 23(3):201-208. PubMed ID: 31101540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer adjuvant radiotherapy target volume design: based on the postoperative local recurrence spatial location.
    Yu W; Hu W; Shui Y; Zhu X; Li C; Ren X; Bai X; Yu R; Shen L; Liang T; Zheng L; Wei Q
    Radiat Oncol; 2016 Oct; 11(1):138. PubMed ID: 27756417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design.
    Dholakia AS; Kumar R; Raman SP; Moore JA; Ellsworth S; McNutt T; Laheru DA; Jaffee E; Cameron JL; Tran PT; Hobbs RF; Wolfgang CL; Herman JM
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1007-15. PubMed ID: 24267969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Radiation Treatment Volumes for Borderline Resectable Pancreatic Cancer in Contemporary Clinical Trials.
    Bluemel TS; Kharofa J
    Am J Clin Oncol; 2020 Sep; 43(9):648-653. PubMed ID: 32889835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles.
    Zhu X; Cao Y; Ju X; Zhao X; Jiang L; Ye Y; Shen Y; Cao F; Qing S; Zhang H
    Cancer Sci; 2021 Jan; 112(1):287-295. PubMed ID: 32418280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
    Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM
    Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.
    Gkika E; Adebahr S; Kirste S; Schimek-Jasch T; Wiehle R; Claus R; Wittel U; Nestle U; Baltas D; Grosu AL; Brunner TB
    Strahlenther Onkol; 2017 Jun; 193(6):433-443. PubMed ID: 28138949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design.
    Zhu X; Ju X; Cao Y; Shen Y; Cao F; Qing S; Fang F; Jia Z; Zhang H
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):101-110. PubMed ID: 30684663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer.
    Nichols RC; Huh SN; Prado KL; Yi BY; Sharma NK; Ho MW; Hoppe BS; Mendenhall NP; Li Z; Regine WF
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):158-63. PubMed ID: 22245197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative localization of porta hepatis and abdominal vasculature in pancreatic malignancies: implications for postoperative radiotherapy planning.
    Kresl JJ; Bonner JA; Bender CE; Grill JP; Gunderson LL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):51-6. PubMed ID: 9300739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].
    Sefrová J; Paluska ; Odrázka K; Belobradek Z; Hoffmann P; Prosvic P; Brod'ák M; Louda M; Macingová Z; Vosmik M
    Klin Onkol; 2010; 23(4):256-63. PubMed ID: 20806824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric and dosimetric comparison of organs at risk between the prone and supine positions in postoperative radiotherapy for prostate cancer.
    Sawayanagi S; Yamashita H; Ogita M; Kiritoshi T; Nakamoto T; Abe O; Nakagawa K
    Radiat Oncol; 2018 Apr; 13(1):70. PubMed ID: 29665832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence.
    Sun W; Leong CN; Zhang Z; Lu JJ
    Radiat Oncol; 2010 Apr; 5():28. PubMed ID: 20398316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
    Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
    Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory movement of upper abdominal organs and its effect on radiotherapy planning in pancreatic cancer.
    Gwynne S; Wills L; Joseph G; John G; Staffurth J; Hurt C; Mukherjee S
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):713-9. PubMed ID: 19733469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
    Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
    Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinoma.
    van der Geld YG; van Triest B; Verbakel WF; van Sörnsen de Koste JR; Senan S; Slotman BJ; Lagerwaard FJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1215-20. PubMed ID: 18954715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer.
    Dawson LA; Anzai Y; Marsh L; Martel MK; Paulino A; Ship JA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1117-26. PubMed ID: 10725621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.